Evidence map›Paper›PMID 28526019›Full record

ArticleMalaria journal2017

Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage.

Christopher Pell, Rupam Tripura, Chea Nguon, Phaikyeong Cheah, Chan Davoeung, Chhouen Heng, Lim Dara, Ma Sareth, Arjen Dondorp, Lorenz von Seidlein and 1 more

Abstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Trial
  9. Article
  10. Article
  11. Article
  12. Mass Drug Administration: Contextual Factor Considerations.The American journal of tropical medicine and hygiene · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christopher PellCentre for Social Science and Global Health, University of Amsterdam, Amsterdam, The Netherlands.
Rupam TripuraMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Chea NguonNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Phaikyeong CheahMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand. Phaikyeong@tropmedres.ac.
Chan DavoeungBattambang Provincial Health Department, Krong Battambang, Cambodia.
Chhouen HengMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Lim DaraMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Ma SarethMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Arjen DondorpMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Lorenz von SeidleinMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Thomas J PetoMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Funding

Wellcome Trust 096527Wellcome Trust 101148/Z/13/Z
6 · The paper itself

Abstract

backgroundMass anti-malarial administration has been proposed as a key component of the Plasmodium falciparum malaria elimination strategy in the Greater Mekong sub-Region. Its effectiveness depends on high levels of coverage in the target population. This article explores the factors that influenced mass anti-malarial administration coverage within a clinical trial in Battambang Province, western Cambodia.

methodsQualitative data were collected through semi-structured interviews and focus group discussions with villagers, in-depth interviews with study staff, trial drop-outs and refusers, and observations in the communities. Interviews were audio-recorded, transcribed and translated from Khmer to English for qualitative content analysis using QSR NVivo.

resultsMalaria was an important health concern and villagers reported a demand for malaria treatment. This was in spite of a fall in incidence over the previous decade and a lack of familiarity with asymptomatic malaria. Participants generally understood the overall study aim and were familiar with study activities. Comprehension of the study rationale was however limited. After the first mass anti-malarial administration, seasonal health complaints that participants attributed to the anti-malarial as "side effects" contributed to a decrease of coverage in round two. Staff therefore adapted the community engagement approach, bringing to prominence local leaders in village meetings. This contributed to a subsequent increase in coverage.

conclusionFuture mass anti-malarial administration must consider seasonal disease patterns and the importance of local leaders taking prominent roles in community engagement. Further research is needed to investigate coverage in scenarios that more closely resemble implementation i.e. without participation incentives, blood sampling and free healthcare.

Indexed as

Community ParticipationHealth Knowledge, Attitudes, PracticeAntimalarialsCambodiaHumansMalaria, FalciparumMass Drug AdministrationQualitative ResearchSocial ConditionsTreatment Adherence and ComplianceAntimalarialsAttitudesCambodiaCommunity engagementCoverageMalariaMass drug administrationQualitativeSocial factors

Identifiers

PMID28526019
PMCPMC5438518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.